Participating sites: AMYPAD Diagnostic (DPMS) and Prognostic (PNHS) Studies
This project has received funding from the Innovative Medicines Initiative 2 Joint undertaking under grant agreement No 115952. This Joint Undertaking receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA.